236 related articles for article (PubMed ID: 15479684)
41. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
42. Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease.
Elewaut D; Van Damme N; De Keyser F; Baeten D; De Paepe P; Van Vlierberghe H; Mielants H; Cuvelier C; Verbruggen G; Veys EM; De Vos M
Acta Gastroenterol Belg; 1998; 61(3):288-94. PubMed ID: 9795455
[TBL] [Abstract][Full Text] [Related]
43. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.
Sato T; Nakai T; Tamura N; Okamoto S; Matsuoka K; Sakuraba A; Fukushima T; Uede T; Hibi T
Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
[TBL] [Abstract][Full Text] [Related]
45. Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis.
Yacyshyn BR
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():265-74. PubMed ID: 7693581
[TBL] [Abstract][Full Text] [Related]
46. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
Gurbindo C; Sabbah S; Menezes J; Justinich C; Marchand R; Seidman EG
J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122
[TBL] [Abstract][Full Text] [Related]
48. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.
Prehn JL; Mehdizadeh S; Landers CJ; Luo X; Cha SC; Wei P; Targan SR
Clin Immunol; 2004 Jul; 112(1):66-77. PubMed ID: 15207783
[TBL] [Abstract][Full Text] [Related]
49. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
[TBL] [Abstract][Full Text] [Related]
50. Molecular mechanisms of sulfasalazine-induced T-cell apoptosis.
Liptay S; Fulda S; Schanbacher M; Bourteele S; Ferri KF; Kroemer G; Adler G; Debatin KM; Schmid RM
Br J Pharmacol; 2002 Nov; 137(5):608-20. PubMed ID: 12381674
[TBL] [Abstract][Full Text] [Related]
51. Cell activation and proliferation in the large intestine of patients with Crohn's disease or ulcerative colitis and controls.
Ullrich R; Schneider T; Schieferdecker HL; Jahn HU; Riecken EO; Zeitz M
Adv Exp Med Biol; 1995; 371B():1281-2. PubMed ID: 7502800
[No Abstract] [Full Text] [Related]
52. T lymphocyte subsets in inflammatory bowel disease: peripheral blood.
Selby WS; Jewell DP
Gut; 1983 Feb; 24(2):99-105. PubMed ID: 6221976
[TBL] [Abstract][Full Text] [Related]
53. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.
Schreiber S; MacDermott RP; Raedler A; Pinnau R; Bertovich MJ; Nash GS
Gastroenterology; 1991 Oct; 101(4):1020-30. PubMed ID: 1889695
[TBL] [Abstract][Full Text] [Related]
54. Crohn's disease and ulcerative colitis mucosal T cells are stimulated by intestinal epithelial cells: implications for immunosuppressive therapy.
Joseph NE; Fiocchi C; Levine AD
Surgery; 1997 Oct; 122(4):809-14; discussion 814-6. PubMed ID: 9347860
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
Sheldon P; Pell P
Adv Exp Med Biol; 1995; 371B():905-8. PubMed ID: 7502923
[No Abstract] [Full Text] [Related]
56. Evidence for an altered T-cell receptor repertoire in Crohn's disease.
Shalon L; Gulwani-Akolkar B; Fisher SE; Akolkar PN; Panja A; Mayer L; Silver J
Autoimmunity; 1994; 17(4):301-7. PubMed ID: 7948612
[TBL] [Abstract][Full Text] [Related]
57. Intrinsic hyperreactivity of mucosal T cells to interleukin-2 in pediatric Crohn's disease.
Kugathasan S; Willis J; Dahms BB; O'Riordan MA; Hupertz V; Binion DG; Boyle JT; Fiocchi C
J Pediatr; 1998 Nov; 133(5):675-81. PubMed ID: 9821428
[TBL] [Abstract][Full Text] [Related]
58. Increased levels of survivin, via association with heat shock protein 90, in mucosal T cells from patients with Crohn's disease.
de Souza HS; West GA; Rebert N; de la Motte C; Drazba J; Fiocchi C
Gastroenterology; 2012 Oct; 143(4):1017-26.e9. PubMed ID: 22749932
[TBL] [Abstract][Full Text] [Related]
59. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.
ten Hove T; van Montfrans C; Peppelenbosch MP; van Deventer SJ
Gut; 2002 Feb; 50(2):206-11. PubMed ID: 11788561
[TBL] [Abstract][Full Text] [Related]
60. Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's disease.
Moret-Tatay I; Nos P; Iborra M; Rausell F; Beltrán B
Clin Exp Immunol; 2024 Jun; 217(1):45-56. PubMed ID: 38247555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
